Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex

NCT03154333 is registered in ClinicalTrials.gov with Castle Creek Pharmaceuticals, LLC as lead sponsor.

NCT NCT03154333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03154333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex
Lead sponsor
Castle Creek Pharmaceuticals, LLC
Phase
Phase 2
Overall status
Terminated
Start date
June 1, 2017
Completion date
October 31, 2018
Enrollment
54 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

epidermolysis bullosa simplex